(Press-News.org) The old proverb “it takes a village to raise a child” also applies to preventing youth suicide, according to UBC Okanagan researchers who found that community support is essential.
In Canada, suicide is the fourth leading cause of death among children under 14 and the second for youth and young adults between 15 and 34 years old. The UBCO Faculty of Health and Social Development researchers say governments, schools and community agencies need to rethink how youth suicide prevention efforts are designed.
And work together on the issue.
“Suicide among young people is a major public health issue and is among the leading causes of death among children and youth around the world,” says Dr. Katrina Plamondon, Associate Professor in the School of Nursing and study co-lead.
The study, led by UBCO’s Equity Science Lab, involved youth, emerging adults, caregivers and service providers through community partnerships. Discussions showed that resilience is not only a personal trait, but also something shaped by supportive communities.
“Most prevention strategies continue to focus on individual behaviours, coping skills or risk profiles,” says Dr. Plamondon. “But this approach overlooks the powerful influence of social, structural, political and environmental conditions on youth wellbeing, and often fails to prevent an incredibly tragic loss of life.”
The study, published recently in Critical Public Health, points to mounting evidence that links suicidality to systemic racism, rural isolation, environmental contamination and inequitable access to basic resources such as clean water and safe housing.
“Despite this,” says study co-author Dr. Shelly Ben-David, “youth voices are rarely included in designing prevention strategies.”
Dr. Ben-David, Associate Professor with UBCO’s School of Social Work, says that many high school students, young adults, caregivers and community service providers all had a voice in this study. The team used collages, stories and metaphors—such as the Japanese art of kintsugi, which repairs broken pottery with gold—to encourage deeper reflection.
“Many participants saw resilience as something repaired and rebuilt ‘with many hands’, showing that young people need care, connection and supportive environments to be resilient,” she adds.
Across all groups, there was a common message: resilience is action taken together. Study participants say resilient communities help youth feel they belong, build strong relationships and feel supported in a positive environment.
“These are key areas to focus on if communities truly hope to reduce youth suicides and promote collective thriving,” adds Dr. Sana Shahram, Assistant Professor with the School of Nursing.
Focusing on community–based strategies and place-based interventions opens the door to more effective suicide prevention, explains Dr. Shahram, who co-directs the Equity Science Lab with Dr. Plamondon.
“In this study, we heard from young people and the supportive adults in their lives, showing that resilient communities are active, engaged places where youth feel not only sheltered from harm, but empowered to contribute, collaborate and express themselves,” she adds.
This approach means addressing the current social and structural determinants of health that shape young people’s lives, instead of putting all the responsibility on the individual to cope and recover.
“There is an urgent need for community-based approaches that invest in youth, not only because adults in their lives want to protect them, but also because everyone’s fate is inherently tied to their thriving,” Dr. Shahram adds. “Together we can create a pathway to reimagining how communities organize around suicide prevention and create environments where our young people can truly thrive.”
Along with faculty in the School of Nursing and the School of Social Work, the study was conducted with support from Melissa Feddersen, manager of UBCO’s Campus Wellness and Education team.
END
New UBCO research challenges traditional teen suicide prevention models
Community care, not individual coping skills, at the core of youth suicide prevention
2025-12-12
ELSE PRESS RELEASES FROM THIS DATE:
Diversity language in US medical research agency grants declined 25% since 2024
2025-12-12
Words reflecting diversity language have appeared less frequently in grants awarded by the National Institutes of Health (NIH) since the 2024 US presidential election, with a 25% relative decrease between January 2024 and June 2025, finds a study in the Christmas issue of The BMJ.
News reports have indicated that US federal agencies have recently limited or discouraged use of words related to diversity, health inequities, and other scientific subjects commanding political attention in NIH research grants.
News reports also suggest that researchers may be modifying their language or research topics to align with federal ...
Concern over growing use of AI chatbots to stave off loneliness
2025-12-12
AI chatbot systems, such as ChatGPT, Claude, and Copilot, are used increasingly as confidants of choice, but turning to AI chatbots for companionship and emotional support is a cause for concern, especially in younger people, say experts in the Christmas issue of The BMJ.
They warn that “we might be witnessing a generation learning to form emotional bonds with entities that lack capacities for human-like empathy, care, and relational attunement” and say evidence based strategies for reducing ...
Biomedical authors often call a reference “recent” — even when it is decades old, analysis shows
2025-12-12
Authors in biomedical journals frequently describe cited evidence as “recent,” yet the actual age of the references behind these phrases has rarely been measured.
To measure how recent the "recent" studies really are, researchers based in Spain analysed 1000 biomedical articles containing 20 predefined “recent” expressions directly linked to a citation.
Their findings in the Christmas issue of The BMJ show that the citation lag ranged from 0 to 37 years, with a median of 4 years and a mean of 5.5 years.
The most frequent ...
The Lancet: New single dose oral treatment for gonorrhoea effectively combats drug-resistant infections, trial finds
2025-12-12
A single-dose oral medication called zoliflodacin shows promise as a new treatment for antibiotic-resistant gonorrhoea, according to a phase 3 clinical trial published in The Lancet. The study found that one dose of zoliflodacin was as effective as the current standard treatment, which combines two antibiotics: an injection of ceftriaxone followed by an oral dose of azithromycin.
Gonorrhoea is one of the most common sexually transmitted infections, affecting over 82 million people globally each year. However, it is increasingly difficult to treat as the bacteria that cause ...
Proton therapy shows survival benefit in Phase III trial for patients with head and neck cancers
2025-12-12
At five years, 90.9% of proton patients were alive compared to 81% with traditional radiation
Proton therapy also showed benefits in quality of life, such as less feeding tube dependence, less difficulty swallowing, less dry mouth, and higher immune cell counts
Study represents the largest randomized Phase III trial comparing proton to traditional radiation with photons for oropharyngeal cancer patients
HOUSTON, DECEMBER 11, 2025 ― A new study published today in The Lancet showed a significant ...
Blood test reveals prognosis after cardiac arrest
2025-12-12
A blood biomarker yet to be used in cardiac arrest care can give a clearer picture of the extent of brain damage after a cardiac arrest. This has been shown in a large international multicentre study led by researchers at Lund University that has been published in The Lancet Respiratory Medicine. Worldwide, around four million people each year suffer a sudden cardiac arrest
“This will transform care for these patients,” says researcher Marion Moseby Knappe.
Key facts about the study: clinical prospective multicentre study // 819 patients // out-of- hospital cardiac arrest //
A simple blood test that can very accurately predict the chance of survival with good recovery ...
UBCO study finds microdosing can temporarily improve mood, creativity
2025-12-12
A new UBC Okanagan study found that people who microdose psychedelics feel better on the days they take them—but those boosts don’t seem to last.
This suggests, says Dr. Michelle St. Pierre, that perceived benefits may be acute rather than long lasting.
Dr. St. Pierre is a post-doctoral psychology researcher with UBCO’s Irving K. Barber Faculty of Arts and Sciences. She recently published a study in Psychopharmacology that tracks the daily experiences of people who microdose with psychedelics.
Microdosing involves ingesting small amounts of a psychedelic substance, commonly psilocybin mushrooms or lysergic acid diethylamide (LSD).
“Most ...
An ECOG-ACRIN imaging study solves a long-standing gap in metastatic breast cancer research and care: accurately measuring treatment response in patients with bone metastases
2025-12-11
A prospective, multicenter cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has validated an improved method for predicting treatment benefits in patients with hormone receptor-positive (HR+) metastatic breast cancer that has spread primarily or exclusively to the bones. These patients make up a large portion of individuals who are living with advanced breast cancer—yet are routinely excluded from clinical trials that rely on standard imaging-based assessments (i.e., RECIST 1.1). The study demonstrated that metabolic change assessed by FDG-PET/CT accurately predicted progression-free ...
Cleveland Clinic presents final results of phase 1 clinical trial of preventive breast cancer vaccine study
2025-12-11
December 11, 2025, CLEVELAND: Cleveland Clinic researchers are presenting final Phase 1 data from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.
The study team found that the investigational vaccine produced an immune response in the majority (74%) of all participants and was safe and well tolerated. They determined the maximum tolerated dose and described that side effects primarily consisted of mild skin inflammation at the injection site. The findings, which will inform the ...
Nationally renowned anesthesiology physician-scientist and clinical operations leader David Mintz, MD, PhD, named Chair of the Department of Anesthesiology at the UM School of Medicine
2025-12-11
University of Maryland School of Medicine Dean Mark T. Gladwin, MD, along with University of Maryland Medical Center (UMMC) President Bert O’Malley, MD, today announced the appointment of C. David Mintz, MD, PhD, to be the next Chair of the Department of Anesthesiology, and Chief of the Anesthesiology Clinical Service (“Chief of Anesthesiology”) at UMMC. Dr. Mintz, a neuroanesthesiologist and nationally recognized leader in research, education, and perioperative operations, will be installed as the Martin Helrich Endowed Professor and Chair of Anesthesiology. He will begin his new position in July, 2026.
Dr. Mintz brings an ...
LAST 30 PRESS RELEASES:
New UBCO research challenges traditional teen suicide prevention models
Diversity language in US medical research agency grants declined 25% since 2024
Concern over growing use of AI chatbots to stave off loneliness
Biomedical authors often call a reference “recent” — even when it is decades old, analysis shows
The Lancet: New single dose oral treatment for gonorrhoea effectively combats drug-resistant infections, trial finds
Proton therapy shows survival benefit in Phase III trial for patients with head and neck cancers
Blood test reveals prognosis after cardiac arrest
UBCO study finds microdosing can temporarily improve mood, creativity
An ECOG-ACRIN imaging study solves a long-standing gap in metastatic breast cancer research and care: accurately measuring treatment response in patients with bone metastases
Cleveland Clinic presents final results of phase 1 clinical trial of preventive breast cancer vaccine study
Nationally renowned anesthesiology physician-scientist and clinical operations leader David Mintz, MD, PhD, named Chair of the Department of Anesthesiology at the UM School of Medicine
Clean water access improves child health in Mozambique, study shows
Study implicates enzyme in neurodegenerative conditions
Tufts professor named Fellow of the National Academy of Inventors
Tiny new device could enable giant future quantum computers
Tracing a path through photosynthesis to food security
First patient in Arizona treated with new immune-cell therapy at HonorHealth Research Institute
Studies investigate how AI can aid clinicians in analyzing medical images
Researchers pitch strategies to identify potential fraudulent participants in online qualitative research
Sweeping study shows similar genetic factors underlie multiple psychiatric disorders
How extreme weather events affect agricultural trade between US states
Smallholder farms maintain strong pollinator diversity – even when far from forests
Price of a bot army revealed across hundreds of online platforms worldwide – from TikTok to Amazon
Warblers borrow color-related genes from evolutionary neighbors, study finds
Heat signaling from plants is an ancient pollinator signal
New index reveals the economics underlying the online manipulation economy
High-resolution satellite observations reveal facility-level methane emissions worldwide
Researchers discover how Ebola and Marburg disrupt the gastrointestinal tract
Feeling the heat
Eastward earthquake rupture progression along the Main Marmara Fault towards Istanbul
[Press-News.org] New UBCO research challenges traditional teen suicide prevention modelsCommunity care, not individual coping skills, at the core of youth suicide prevention